首页 > 最新文献

Biomedical Instrumentation and Technology最新文献

英文 中文
ISO 4135, Fourth Edition: Two Decades of Progress in ISO/TC 121. ISO 4135,第四版:ISO/TC 121的二十年进展。
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.2345/1943-5967-56.1.29
Debra R Milamed

The publication of ISO 4135, Anaesthetic and respiratory equipment-Vocabulary, fourth edition, highlights expansion of the scope of the International Organization for Standardization (ISO) Technical Committee (TC) 121 and its Subcommittees and Working Groups during two decades of work. This document stands alongside ISO 19223:2019, Lung ventilators and related equipment-Vocabulary and semantics, to promote consistency and specificity of terminology across ISO/TC 121 standards.

ISO 4135《麻醉和呼吸设备-词汇》第四版的出版,突出了国际标准化组织(ISO)技术委员会(TC) 121及其小组委员会和工作组在二十年的工作中扩大了范围。本文件与ISO 19223:2019《肺呼吸机及相关设备-词汇和语义》保持一致,以促进ISO/TC 121标准中术语的一致性和特异性。
{"title":"ISO 4135, Fourth Edition: Two Decades of Progress in ISO/TC 121.","authors":"Debra R Milamed","doi":"10.2345/1943-5967-56.1.29","DOIUrl":"https://doi.org/10.2345/1943-5967-56.1.29","url":null,"abstract":"<p><p>The publication of ISO 4135, Anaesthetic and respiratory equipment-Vocabulary, fourth edition, highlights expansion of the scope of the International Organization for Standardization (ISO) Technical Committee (TC) 121 and its Subcommittees and Working Groups during two decades of work. This document stands alongside ISO 19223:2019, Lung ventilators and related equipment-Vocabulary and semantics, to promote consistency and specificity of terminology across ISO/TC 121 standards.</p>","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":" ","pages":"29-32"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39746484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Signaling Patient Oxygen Desaturation with Enhanced Pulse Oximetry Tones. 用增强型脉搏血氧计音调向患者发出血氧饱和度信号。
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.2345/1943-5967-56.2.46
P. Sanderson, R. Loeb, H. Liley, David Liu, E. Paterson, Kelly Hinckfuss, J. Zestic
Manufacturers could improve the pulse tones emitted by pulse oximeters to support more accurate identification of a patient's peripheral oxygen saturation (SpO2) range. In this article, we outline the strengths and limitations of the variable-pitch tone that represents SpO2 of each detected pulse, and we argue that enhancements to the tone to demarcate clinically relevant ranges are feasible and desirable. The variable-pitch tone is an appreciated and trusted feature of the pulse oximeter's user interface. However, studies show that it supports relative judgments of SpO2 trends over time and is less effective at supporting absolute judgments about the SpO2 number or conveying when SpO2 moves into clinically important ranges. We outline recent studies that tested whether acoustic enhancements to the current tone could convey clinically important ranges more directly, without necessarily using auditory alarms. The studies cover the use of enhanced variable-pitch pulse oximeter tones for neonatal and adult use. Compared with current tones, the characteristics of the enhanced tones represent improvements that are both clinically relevant and statistically significant. We outline the benefits of enhanced tones, as well as discuss constraints of which developers of enhanced tones should be aware if enhancements are to be successful.
制造商可以改进脉搏血氧计发出的脉搏音,以支持更准确地识别患者的外周血氧饱和度(SpO2)范围。在这篇文章中,我们概述了代表每个检测到的脉冲的SpO2的可变音调的强度和局限性,我们认为增强音调以划分临床相关范围是可行和可取的。可变音调是脉搏血氧计用户界面的一个值得赞赏和信赖的特征。然而,研究表明,它支持对SpO2随时间变化趋势的相对判断,而在支持SpO2值的绝对判断或SpO2进入临床重要范围时的输送方面效果较差。我们概述了最近的研究,这些研究测试了当前音调的声学增强是否可以更直接地传达临床上重要的范围,而不必使用听觉警报。这些研究涵盖了增强型可变螺距脉搏血氧计音调在新生儿和成人中的使用。与当前音调相比,增强音调的特征表示具有临床相关性和统计学意义的改善。我们概述了增强音调的好处,并讨论了如果增强要成功,增强音调的开发人员应该意识到的限制。
{"title":"Signaling Patient Oxygen Desaturation with Enhanced Pulse Oximetry Tones.","authors":"P. Sanderson, R. Loeb, H. Liley, David Liu, E. Paterson, Kelly Hinckfuss, J. Zestic","doi":"10.2345/1943-5967-56.2.46","DOIUrl":"https://doi.org/10.2345/1943-5967-56.2.46","url":null,"abstract":"Manufacturers could improve the pulse tones emitted by pulse oximeters to support more accurate identification of a patient's peripheral oxygen saturation (SpO2) range. In this article, we outline the strengths and limitations of the variable-pitch tone that represents SpO2 of each detected pulse, and we argue that enhancements to the tone to demarcate clinically relevant ranges are feasible and desirable. The variable-pitch tone is an appreciated and trusted feature of the pulse oximeter's user interface. However, studies show that it supports relative judgments of SpO2 trends over time and is less effective at supporting absolute judgments about the SpO2 number or conveying when SpO2 moves into clinically important ranges. We outline recent studies that tested whether acoustic enhancements to the current tone could convey clinically important ranges more directly, without necessarily using auditory alarms. The studies cover the use of enhanced variable-pitch pulse oximeter tones for neonatal and adult use. Compared with current tones, the characteristics of the enhanced tones represent improvements that are both clinically relevant and statistically significant. We outline the benefits of enhanced tones, as well as discuss constraints of which developers of enhanced tones should be aware if enhancements are to be successful.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"56 2 1","pages":"46-57"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43637579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Detecting Unusual Intravenous Infusion Alerting Patterns with Machine Learning Algorithms. 用机器学习算法检测异常静脉输液警报模式。
Q4 Medicine Pub Date : 2022-01-01 DOI: 10.2345/1943-5967-56.2.58
Marian Obuseh, Denny Yu, P. DeLaurentis
OBJECTIVETo detect unusual infusion alerting patterns using machine learning (ML) algorithms as a first step to advance safer inpatient intravenous administration of high-alert medications.MATERIALS AND METHODSWe used one year of detailed propofol infusion data from a hospital. Interpretable and clinically relevant variables were feature engineered, and data points were aggregated per calendar day. A univariate (maximum times-limit) moving range (mr) control chart was used to simulate clinicians' common approach to identifying unusual infusion alerting patterns. Three different unsupervised multivariate ML-based anomaly detection algorithms (Local Outlier Factor, Isolation Forest, and k-Nearest Neighbors) were used for the same purpose. Results from the control chart and ML algorithms were compared.RESULTSThe propofol data had 3,300 infusion alerts, 92% of which were generated during the day shift and seven of which had a times-limit greater than 10. The mr-chart identified 15 alert pattern anomalies. Different thresholds were set to include the top 15 anomalies from each ML algorithm. A total of 31 unique ML anomalies were grouped and ranked by agreeability. All algorithms agreed on 10% of the anomalies, and at least two algorithms agreed on 36%. Each algorithm detected one specific anomaly that the mr-chart did not detect. The anomaly represented a day with 71 propofol alerts (half of which were overridden) generated at an average rate of 1.06 per infusion, whereas the moving alert rate for the week was 0.35 per infusion.DISCUSSIONThese findings show that ML-based algorithms are more robust than control charts in detecting unusual alerting patterns. However, we recommend using a combination of algorithms, as multiple algorithms serve a benchmarking function and allow researchers to focus on data points with the highest algorithm agreeability.CONCLUSIONUnsupervised ML algorithms can assist clinicians in identifying unusual alert patterns as a first step toward achieving safer infusion practices.
目的利用机器学习(ML)算法检测异常输液报警模式,以提高住院患者静脉给药的安全性。材料与方法我们使用了一家医院一年的异丙酚输注的详细数据。对可解释的和临床相关的变量进行特征设计,并按日历日汇总数据点。单变量(最大时限)移动范围(mr)控制图用于模拟临床医生识别异常输液报警模式的常用方法。三种不同的无监督多变量基于ml的异常检测算法(局部离群因子、隔离森林和k近邻)被用于相同的目的。比较了控制图和ML算法的结果。结果异丙酚数据有3300个输液报警,92%发生在白班,其中7个时限大于10。mr图确定了15个异常的警报模式。设置不同的阈值,以包括每个ML算法的前15个异常。共有31个独特的ML异常被分组并按亲和性排名。所有算法在10%的异常情况下达成一致,至少有两种算法在36%的异常情况下达成一致。每个算法都检测到一个特定的异常,而磁共振图没有检测到。异常代表一天71次异丙酚警报(其中一半被覆盖),平均每次输注1.06次,而一周的移动警报率为0.35次输注。这些发现表明,在检测异常报警模式方面,基于ml的算法比控制图更健壮。然而,我们建议使用算法的组合,因为多个算法服务于基准测试功能,并允许研究人员专注于具有最高算法一致性的数据点。结论:无监督ML算法可以帮助临床医生识别异常警报模式,作为实现更安全输液实践的第一步。
{"title":"Detecting Unusual Intravenous Infusion Alerting Patterns with Machine Learning Algorithms.","authors":"Marian Obuseh, Denny Yu, P. DeLaurentis","doi":"10.2345/1943-5967-56.2.58","DOIUrl":"https://doi.org/10.2345/1943-5967-56.2.58","url":null,"abstract":"OBJECTIVE\u0000To detect unusual infusion alerting patterns using machine learning (ML) algorithms as a first step to advance safer inpatient intravenous administration of high-alert medications.\u0000\u0000\u0000MATERIALS AND METHODS\u0000We used one year of detailed propofol infusion data from a hospital. Interpretable and clinically relevant variables were feature engineered, and data points were aggregated per calendar day. A univariate (maximum times-limit) moving range (mr) control chart was used to simulate clinicians' common approach to identifying unusual infusion alerting patterns. Three different unsupervised multivariate ML-based anomaly detection algorithms (Local Outlier Factor, Isolation Forest, and k-Nearest Neighbors) were used for the same purpose. Results from the control chart and ML algorithms were compared.\u0000\u0000\u0000RESULTS\u0000The propofol data had 3,300 infusion alerts, 92% of which were generated during the day shift and seven of which had a times-limit greater than 10. The mr-chart identified 15 alert pattern anomalies. Different thresholds were set to include the top 15 anomalies from each ML algorithm. A total of 31 unique ML anomalies were grouped and ranked by agreeability. All algorithms agreed on 10% of the anomalies, and at least two algorithms agreed on 36%. Each algorithm detected one specific anomaly that the mr-chart did not detect. The anomaly represented a day with 71 propofol alerts (half of which were overridden) generated at an average rate of 1.06 per infusion, whereas the moving alert rate for the week was 0.35 per infusion.\u0000\u0000\u0000DISCUSSION\u0000These findings show that ML-based algorithms are more robust than control charts in detecting unusual alerting patterns. However, we recommend using a combination of algorithms, as multiple algorithms serve a benchmarking function and allow researchers to focus on data points with the highest algorithm agreeability.\u0000\u0000\u0000CONCLUSION\u0000Unsupervised ML algorithms can assist clinicians in identifying unusual alert patterns as a first step toward achieving safer infusion practices.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"56 2 1","pages":"58-70"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41341990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Assessing Detergent Residuals for Reusable Device Cleaning Validations. 评估可重复使用设备清洁验证的洗涤剂残留量。
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.2345/0890-8205-55.4.165
T. Kremer, D. Olsen, Chad Summers, Alpa Patel, Julie Hoover, M. Cieślak, D. Znamensky, G. Mcdonnell
Cleaning chemistries are detergent-based formulations that are used during the processing of reusable medical devices. Manufacturers are responsible for demonstrating the safety of cleaning formulations when they are used during a device processing cycle, including the risk of device-associated cytotoxicity over the concentration ranges for recommended use and rinsing during cleaning. However, no regulation currently exists requiring manufacturers to demonstrate such safety. Although manufacturers' safety data sheets (SDSs) provide information on the safe use of chemicals for users, this information may not provide sufficient detail to determine the risks of residual chemicals on device surfaces. SDSs are not required to contain a comprehensive list of chemicals used, only those of risk to the user. They should be supplemented with information on the correct concentrations that should be used for cleaning, as well as instructions on the rinsing required to reduce the levels of chemicals to safe (nontoxic) levels prior to further processing. Supporting data, such as toxicity profiles or cytotoxicity data that support the instructions for use, would provide medical device manufacturers and healthcare personnel with the necessary information to make informed decisions about selection and correct use of detergents. In the current work, cytotoxicity profiles for eight commonly used cleaning formulations available internationally were studied. Although all of these products are indicated for use in the cleaning of reusable medical devices, results vary across the serial dilution curves and are not consistent among detergent types. The information presented here can be leveraged by both medical device manufacturers and processing department personnel to properly assess residual detergent risks during processing. This work also serves as a call to cleaning formulation manufacturers to provide this information for all chemistries.
清洁化学品是在可重复使用的医疗器械加工过程中使用的基于洗涤剂的配方。制造商有责任证明在器械加工周期中使用的清洁制剂的安全性,包括在推荐使用的浓度范围内以及在清洁过程中冲洗时与器械相关的细胞毒性的风险。然而,目前没有任何法规要求制造商证明此类安全性。尽管制造商的安全数据表(SDS)为用户提供了有关化学品安全使用的信息,但这些信息可能无法提供足够的细节来确定设备表面残留化学品的风险。SDS不需要包含所用化学品的全面清单,只需要包含对用户有风险的化学品。应补充有关清洁所用正确浓度的信息,以及在进一步处理前将化学品水平降至安全(无毒)水平所需的冲洗说明。支持数据,如支持使用说明的毒性特征或细胞毒性数据,将为医疗器械制造商和医护人员提供必要的信息,以便就洗涤剂的选择和正确使用做出明智的决定。在目前的工作中,研究了国际上常用的八种清洁配方的细胞毒性特征。尽管所有这些产品都被指示用于可重复使用的医疗器械的清洁,但在系列稀释曲线上的结果各不相同,并且在不同的洗涤剂类型之间并不一致。医疗器械制造商和加工部门人员都可以利用此处提供的信息来正确评估加工过程中残留洗涤剂的风险。这项工作也呼吁清洁配方制造商为所有化学品提供这些信息。
{"title":"Assessing Detergent Residuals for Reusable Device Cleaning Validations.","authors":"T. Kremer, D. Olsen, Chad Summers, Alpa Patel, Julie Hoover, M. Cieślak, D. Znamensky, G. Mcdonnell","doi":"10.2345/0890-8205-55.4.165","DOIUrl":"https://doi.org/10.2345/0890-8205-55.4.165","url":null,"abstract":"Cleaning chemistries are detergent-based formulations that are used during the processing of reusable medical devices. Manufacturers are responsible for demonstrating the safety of cleaning formulations when they are used during a device processing cycle, including the risk of device-associated cytotoxicity over the concentration ranges for recommended use and rinsing during cleaning. However, no regulation currently exists requiring manufacturers to demonstrate such safety. Although manufacturers' safety data sheets (SDSs) provide information on the safe use of chemicals for users, this information may not provide sufficient detail to determine the risks of residual chemicals on device surfaces. SDSs are not required to contain a comprehensive list of chemicals used, only those of risk to the user. They should be supplemented with information on the correct concentrations that should be used for cleaning, as well as instructions on the rinsing required to reduce the levels of chemicals to safe (nontoxic) levels prior to further processing. Supporting data, such as toxicity profiles or cytotoxicity data that support the instructions for use, would provide medical device manufacturers and healthcare personnel with the necessary information to make informed decisions about selection and correct use of detergents. In the current work, cytotoxicity profiles for eight commonly used cleaning formulations available internationally were studied. Although all of these products are indicated for use in the cleaning of reusable medical devices, results vary across the serial dilution curves and are not consistent among detergent types. The information presented here can be leveraged by both medical device manufacturers and processing department personnel to properly assess residual detergent risks during processing. This work also serves as a call to cleaning formulation manufacturers to provide this information for all chemistries.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 4 1","pages":"165-170"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47343779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Usability Engineering Recommendations for Next-Gen Integrated Interoperable Medical Devices. 下一代集成互操作医疗设备的可用性工程建议。
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.2345/0890-8205-55.4.132
P. Masci, S. Weininger
This article reports on the development of usability engineering recommendations for next-generation integrated interoperable medical devices. A model-based hazard analysis method is used to reason about possible design anomalies in interoperability functions that could lead to use errors. Design recommendations are identified that can mitigate design problems. An example application of the method is presented based on an integrated medical system prototype for postoperative care. The AAMI/UL technical committee used the results of the described analysis to inform the creation of the Interoperability Usability Concepts, Annex J, which is included in the first edition of the new ANSI/AAMI/UL 2800-1:2019 standard on medical device interoperability. The presented work is valuable to experts developing future revisions of the interoperability standard, as it documents key aspects of the analysis method used to create part of the standard. The contribution is also valuable to manufacturers, as it demonstrates how to perform a model-based analysis of use-related aspects of a medical system at the early stages of development, when a concrete implementation of the system is not yet available.
本文报告了下一代集成互操作医疗设备的可用性工程建议的发展。采用基于模型的危害分析方法对互操作性功能中可能导致使用错误的设计异常进行推理。确定了可以减轻设计问题的设计建议。基于一个综合医疗系统的术后护理原型,给出了该方法的应用实例。AAMI/UL技术委员会使用所描述的分析结果为互操作性可用性概念(附录J)的创建提供了信息,该概念包含在新的医疗器械互操作性标准ANSI/AAMI/UL 2800-1:2019的第一版中。所介绍的工作对于开发互操作性标准未来修订版的专家很有价值,因为它记录了用于创建部分标准的分析方法的关键方面。该贡献对制造商也很有价值,因为它演示了如何在开发的早期阶段,当系统的具体实现尚未可用时,对医疗系统的使用相关方面进行基于模型的分析。
{"title":"Usability Engineering Recommendations for Next-Gen Integrated Interoperable Medical Devices.","authors":"P. Masci, S. Weininger","doi":"10.2345/0890-8205-55.4.132","DOIUrl":"https://doi.org/10.2345/0890-8205-55.4.132","url":null,"abstract":"This article reports on the development of usability engineering recommendations for next-generation integrated interoperable medical devices. A model-based hazard analysis method is used to reason about possible design anomalies in interoperability functions that could lead to use errors. Design recommendations are identified that can mitigate design problems. An example application of the method is presented based on an integrated medical system prototype for postoperative care. The AAMI/UL technical committee used the results of the described analysis to inform the creation of the Interoperability Usability Concepts, Annex J, which is included in the first edition of the new ANSI/AAMI/UL 2800-1:2019 standard on medical device interoperability. The presented work is valuable to experts developing future revisions of the interoperability standard, as it documents key aspects of the analysis method used to create part of the standard. The contribution is also valuable to manufacturers, as it demonstrates how to perform a model-based analysis of use-related aspects of a medical system at the early stages of development, when a concrete implementation of the system is not yet available.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 4 1","pages":"132-142"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42703535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing Detergent Residuals for Reusable Device Cleaning Validations. 评估可重复使用设备清洁验证的洗涤剂残留量。
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.2345/0899-8205-55.4.165
Terra A Kremer, Daniel Olsen, Chad Summers, Alpa Patel, Julie Hoover, Marcin Cieslak, Dmitry Znamensky, Gerald McDonnell

Cleaning chemistries are detergent-based formulations that are used during the processing of reusable medical devices. Manufacturers are responsible for demonstrating the safety of cleaning formulations when they are used during a device processing cycle, including the risk of device-associated cytotoxicity over the concentration ranges for recommended use and rinsing during cleaning. However, no regulation currently exists requiring manufacturers to demonstrate such safety. Although manufacturers' safety data sheets (SDSs) provide information on the safe use of chemicals for users, this information may not provide sufficient detail to determine the risks of residual chemicals on device surfaces. SDSs are not required to contain a comprehensive list of chemicals used, only those of risk to the user. They should be supplemented with information on the correct concentrations that should be used for cleaning, as well as instructions on the rinsing required to reduce the levels of chemicals to safe (nontoxic) levels prior to further processing. Supporting data, such as toxicity profiles or cytotoxicity data that support the instructions for use, would provide medical device manufacturers and healthcare personnel with the necessary information to make informed decisions about selection and correct use of detergents. In the current work, cytotoxicity profiles for eight commonly used cleaning formulations available internationally were studied. Although all of these products are indicated for use in the cleaning of reusable medical devices, results vary across the serial dilution curves and are not consistent among detergent types. The information presented here can be leveraged by both medical device manufacturers and processing department personnel to properly assess residual detergent risks during processing. This work also serves as a call to cleaning formulation manufacturers to provide this information for all chemistries.

清洁化学品是在可重复使用的医疗器械加工过程中使用的基于洗涤剂的配方。制造商有责任证明在器械加工周期中使用的清洁配方的安全性,包括在推荐使用的浓度范围内与器械相关的细胞毒性风险和清洗期间的冲洗。然而,目前没有任何法规要求制造商证明这种安全性。尽管制造商的安全数据表(sds)为用户提供了关于化学品安全使用的信息,但这些信息可能无法提供足够的细节来确定设备表面残留化学品的风险。sds不需要包含所使用化学品的全面清单,只需要包含对用户有风险的化学品。应补充说明用于清洁的正确浓度,以及在进一步处理之前将化学品水平降低到安全(无毒)水平所需的冲洗说明。支持性数据,如支持使用说明的毒性概况或细胞毒性数据,将为医疗设备制造商和保健人员提供必要的信息,以便在选择和正确使用洗涤剂方面做出明智的决定。在目前的工作中,研究了国际上常用的八种清洁配方的细胞毒性。虽然所有这些产品都指示用于可重复使用的医疗设备的清洁,但结果在系列稀释曲线上有所不同,并且在洗涤剂类型之间不一致。医疗设备制造商和加工部门人员都可以利用这里提供的信息来正确评估加工过程中残留洗涤剂的风险。这项工作也可以作为清洁配方制造商的呼吁,为所有化学品提供这些信息。
{"title":"Assessing Detergent Residuals for Reusable Device Cleaning Validations.","authors":"Terra A Kremer,&nbsp;Daniel Olsen,&nbsp;Chad Summers,&nbsp;Alpa Patel,&nbsp;Julie Hoover,&nbsp;Marcin Cieslak,&nbsp;Dmitry Znamensky,&nbsp;Gerald McDonnell","doi":"10.2345/0899-8205-55.4.165","DOIUrl":"https://doi.org/10.2345/0899-8205-55.4.165","url":null,"abstract":"<p><p>Cleaning chemistries are detergent-based formulations that are used during the processing of reusable medical devices. Manufacturers are responsible for demonstrating the safety of cleaning formulations when they are used during a device processing cycle, including the risk of device-associated cytotoxicity over the concentration ranges for recommended use and rinsing during cleaning. However, no regulation currently exists requiring manufacturers to demonstrate such safety. Although manufacturers' safety data sheets (SDSs) provide information on the safe use of chemicals for users, this information may not provide sufficient detail to determine the risks of residual chemicals on device surfaces. SDSs are not required to contain a comprehensive list of chemicals used, only those of risk to the user. They should be supplemented with information on the correct concentrations that should be used for cleaning, as well as instructions on the rinsing required to reduce the levels of chemicals to safe (nontoxic) levels prior to further processing. Supporting data, such as toxicity profiles or cytotoxicity data that support the instructions for use, would provide medical device manufacturers and healthcare personnel with the necessary information to make informed decisions about selection and correct use of detergents. In the current work, cytotoxicity profiles for eight commonly used cleaning formulations available internationally were studied. Although all of these products are indicated for use in the cleaning of reusable medical devices, results vary across the serial dilution curves and are not consistent among detergent types. The information presented here can be leveraged by both medical device manufacturers and processing department personnel to properly assess residual detergent risks during processing. This work also serves as a call to cleaning formulation manufacturers to provide this information for all chemistries.</p>","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 4","pages":"165-170"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641418/pdf/i0899-8205-55-4-165.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39600500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality Fade in Medical Device Manufacturing: Thinness of Airway Breathing Circuit Plastic. 医疗器械制造中的质量衰退:气道呼吸回路塑料的厚度。
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.2345/0890-8205-55.4.118
R. Naftalovich, Marko Oydanich, Tolga Berkman, Andrew Iskander
Mechanical respirators typically use a plastic circuit apparatus to pass gases from the ventilator to the patient. Structural integrity of these circuits is crucial for maintaining oxygenation. Anesthesiologists, respiratory therapists, and other critical care professionals rely on the circuit to be free of defects. The American Society for Testing and Materials maintains standards of medical devices and had a standard (titled Standard Specification for Anesthesia Breathing Tubes) that included circuits. This standard, which was last updated in 2008, has since been withdrawn. Lack of a defined standard can invite quality fade-the phenomenon whereby manufacturers deliberately but surreptitiously reduce material quality to widen profit margins. With plastics, this is often in the form of thinner material. A minimum thickness delineated in the breathing circuit standard would help ensure product quality, maintain tolerance to mechanical insults, and avert leaks. Our impression is that over the recent years, the plastic in many of the commercially available breathing circuits has gotten thinner. We experienced a circuit leak in the middle of a laminectomy due to compromised plastic tubing in a location that evaded the safety circuit leak check that is performed prior to surgery. This compromised ventilation and oxygenation in the middle of a surgery in which the patient is positioned prone and hence with a minimally accessible airway; it could have resulted in anoxic brain injury or death. The incident led us to reflect on the degree of thinness of the circuit's plastic.
机械呼吸器通常使用塑料电路装置将气体从呼吸机传递给患者。这些电路的结构完整性对于维持氧合至关重要。麻醉师,呼吸治疗师和其他重症监护专业人员依靠回路无缺陷。美国测试和材料协会维护医疗设备的标准,并有一个标准(题为麻醉呼吸管的标准规范),其中包括电路。该标准上次更新是在2008年,现已被撤销。缺乏明确的标准可能会导致质量下降——制造商故意但偷偷地降低材料质量以扩大利润空间的现象。对于塑料,这通常是以更薄的材料的形式出现的。在呼吸电路标准中描述的最小厚度将有助于确保产品质量,保持对机械损伤的容忍度,并避免泄漏。我们的印象是,近年来,许多商用呼吸回路中的塑料变得越来越薄。我们在椎板切除术中经历了一次回路泄漏,原因是手术前在一个位置的塑料管受损,逃避了安全回路泄漏检查。在手术中,患者俯卧,气道可达性最低,通气和氧合受损;这可能会导致缺氧脑损伤甚至死亡。这一事件引发了我们对电路塑料厚度的思考。
{"title":"Quality Fade in Medical Device Manufacturing: Thinness of Airway Breathing Circuit Plastic.","authors":"R. Naftalovich, Marko Oydanich, Tolga Berkman, Andrew Iskander","doi":"10.2345/0890-8205-55.4.118","DOIUrl":"https://doi.org/10.2345/0890-8205-55.4.118","url":null,"abstract":"Mechanical respirators typically use a plastic circuit apparatus to pass gases from the ventilator to the patient. Structural integrity of these circuits is crucial for maintaining oxygenation. Anesthesiologists, respiratory therapists, and other critical care professionals rely on the circuit to be free of defects. The American Society for Testing and Materials maintains standards of medical devices and had a standard (titled Standard Specification for Anesthesia Breathing Tubes) that included circuits. This standard, which was last updated in 2008, has since been withdrawn. Lack of a defined standard can invite quality fade-the phenomenon whereby manufacturers deliberately but surreptitiously reduce material quality to widen profit margins. With plastics, this is often in the form of thinner material. A minimum thickness delineated in the breathing circuit standard would help ensure product quality, maintain tolerance to mechanical insults, and avert leaks. Our impression is that over the recent years, the plastic in many of the commercially available breathing circuits has gotten thinner. We experienced a circuit leak in the middle of a laminectomy due to compromised plastic tubing in a location that evaded the safety circuit leak check that is performed prior to surgery. This compromised ventilation and oxygenation in the middle of a surgery in which the patient is positioned prone and hence with a minimally accessible airway; it could have resulted in anoxic brain injury or death. The incident led us to reflect on the degree of thinness of the circuit's plastic.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 4 1","pages":"118-120"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48115768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selecting a Passive Network Monitoring Solution for Medical Device Cybersecurity Management. 选择用于医疗设备网络安全管理的被动网络监控解决方案。
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.2345/0890-8205-55.4.121
P. Upendra
The number of cyberattacks and information system breaches in healthcare have grown exponentially, as well as escalated from accidental incidents to targeted and malicious attacks. With medical devices representing a substantial repository of all the assets in a healthcare system, network security and monitoring are critical to ensuring cyber hygiene of these medical devices. Because of the unique challenges of connected medical devices, a passive network monitoring (PNM) solution is preferred for its overall cybersecurity management. This article is intended to provide guidance on selecting PNM solutions while reinforcing the importance of program assessment, project management, and use of leading practices that facilitate the selection and further implementation of PNM solutions for medical devices. The article provides a detailed introduction to connected medical devices and its role in effective care delivery, an overview of network security types and PNM, an overview of the National Institute of Standards and Technology Cybersecurity Framework and its application for program assessment, essentials of project management for PNM solution selection and implementation, key performance indicators for measuring a solution's ability to meet critical cybersecurity needs for medical devices, and lessons learned from the author's professional experience, selective literature review, and leading practices. Rather than describing a complete list of guidelines for selecting PNM solutions, the current work is intended to provide guidance based on the author's experience and leading practices compiled from successful medical device cybersecurity programs.
医疗保健领域的网络攻击和信息系统漏洞数量呈指数级增长,并从意外事件升级为有针对性的恶意攻击。医疗设备是医疗系统中所有资产的重要存储库,网络安全和监控对于确保这些医疗设备的网络卫生至关重要。由于联网医疗设备的独特挑战,被动网络监控(PNM)解决方案是其整体网络安全管理的首选方案。本文旨在为选择PNM解决方案提供指导,同时强调项目评估、项目管理和使用领先实践的重要性,以促进医疗器械PNM解决方法的选择和进一步实施。文章详细介绍了联网医疗设备及其在有效护理中的作用,概述了网络安全类型和PNM,概述了国家标准与技术研究所网络安全框架及其在项目评估中的应用,PNM解决方案选择和实施的项目管理要点,衡量解决方案满足医疗设备关键网络安全需求的能力的关键性能指标,以及从作者的专业经验、选择性文献综述和领先实践中吸取的经验教训。目前的工作不是描述选择PNM解决方案的完整指南列表,而是根据作者的经验和从成功的医疗设备网络安全计划中汇编的领先实践提供指导。
{"title":"Selecting a Passive Network Monitoring Solution for Medical Device Cybersecurity Management.","authors":"P. Upendra","doi":"10.2345/0890-8205-55.4.121","DOIUrl":"https://doi.org/10.2345/0890-8205-55.4.121","url":null,"abstract":"The number of cyberattacks and information system breaches in healthcare have grown exponentially, as well as escalated from accidental incidents to targeted and malicious attacks. With medical devices representing a substantial repository of all the assets in a healthcare system, network security and monitoring are critical to ensuring cyber hygiene of these medical devices. Because of the unique challenges of connected medical devices, a passive network monitoring (PNM) solution is preferred for its overall cybersecurity management. This article is intended to provide guidance on selecting PNM solutions while reinforcing the importance of program assessment, project management, and use of leading practices that facilitate the selection and further implementation of PNM solutions for medical devices. The article provides a detailed introduction to connected medical devices and its role in effective care delivery, an overview of network security types and PNM, an overview of the National Institute of Standards and Technology Cybersecurity Framework and its application for program assessment, essentials of project management for PNM solution selection and implementation, key performance indicators for measuring a solution's ability to meet critical cybersecurity needs for medical devices, and lessons learned from the author's professional experience, selective literature review, and leading practices. Rather than describing a complete list of guidelines for selecting PNM solutions, the current work is intended to provide guidance based on the author's experience and leading practices compiled from successful medical device cybersecurity programs.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 4 1","pages":"121-130"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46305102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Words Matter: A Commentary and Glossary of Definitions for Microbiological Quality. Words Matter:微生物质量定义的评注和词汇表。
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.2345/0890-8205-55.4.143
G. Mcdonnell, Harold S. Baseman, Lena Cordie-Bancroft
In the design, control, and regulation of the manufacturing and supply of microbiologically controlled devices (including sterile devices) and drug products (including cleaning, disinfection, and sterilization processing and/or aseptic process manufacturing), different terms and/or definitions are often used for similar processes or applications internationally. With product innovations (including combination products and cell-based therapy) and global regulatory influences, there is a growing need to harmonize these definitions. The objective of the Kilmer Regulatory Innovation microbiological quality and sterility assurance glossary is to clarify and harmonize the practical use of terms employed by the different parts of regulated healthcare product industries internationally and by regulators of the manufacturing and supply of microbiologically controlled healthcare products internationally. The glossary is expected to continue to evolve, and further industry, academic, and regulatory input is encouraged.
在微生物控制装置(包括无菌装置)和药品(包括清洁、消毒和灭菌处理和/或无菌工艺制造)的制造和供应的设计、控制和监管中,国际上经常使用不同的术语和/或定义用于类似的工艺或应用。随着产品创新(包括组合产品和基于细胞的治疗)和全球监管影响,越来越需要协调这些定义。Kilmer Regulatory Innovation微生物质量和无菌保证术语表的目的是澄清和协调国际受监管医疗保健产品行业不同部门以及国际微生物控制医疗保健产品制造和供应监管机构使用的术语的实际使用。该术语表预计将继续发展,并鼓励进一步的行业、学术和监管投入。
{"title":"Words Matter: A Commentary and Glossary of Definitions for Microbiological Quality.","authors":"G. Mcdonnell, Harold S. Baseman, Lena Cordie-Bancroft","doi":"10.2345/0890-8205-55.4.143","DOIUrl":"https://doi.org/10.2345/0890-8205-55.4.143","url":null,"abstract":"In the design, control, and regulation of the manufacturing and supply of microbiologically controlled devices (including sterile devices) and drug products (including cleaning, disinfection, and sterilization processing and/or aseptic process manufacturing), different terms and/or definitions are often used for similar processes or applications internationally. With product innovations (including combination products and cell-based therapy) and global regulatory influences, there is a growing need to harmonize these definitions. The objective of the Kilmer Regulatory Innovation microbiological quality and sterility assurance glossary is to clarify and harmonize the practical use of terms employed by the different parts of regulated healthcare product industries internationally and by regulators of the manufacturing and supply of microbiologically controlled healthcare products internationally. The glossary is expected to continue to evolve, and further industry, academic, and regulatory input is encouraged.","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 4 1","pages":"143-164"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49491865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Quality Fade in Medical Device Manufacturing: Thinness of Airway Breathing Circuit Plastic. 医疗器械制造中的质量衰退:气道呼吸回路塑料的厚度。
Q4 Medicine Pub Date : 2021-11-01 DOI: 10.2345/0899-8205-55.4.118
Rotem Naftalovich, Marko Oydanich, Tolga Berkman, Andrew John Iskander

Mechanical respirators typically use a plastic circuit apparatus to pass gases from the ventilator to the patient. Structural integrity of these circuits is crucial for maintaining oxygenation. Anesthesiologists, respiratory therapists, and other critical care professionals rely on the circuit to be free of defects. The American Society for Testing and Materials maintains standards of medical devices and had a standard (titled Standard Specification for Anesthesia Breathing Tubes) that included circuits. This standard, which was last updated in 2008, has since been withdrawn. Lack of a defined standard can invite quality fade-the phenomenon whereby manufacturers deliberately but surreptitiously reduce material quality to widen profit margins. With plastics, this is often in the form of thinner material. A minimum thickness delineated in the breathing circuit standard would help ensure product quality, maintain tolerance to mechanical insults, and avert leaks. Our impression is that over the recent years, the plastic in many of the commercially available breathing circuits has gotten thinner. We experienced a circuit leak in the middle of a laminectomy due to compromised plastic tubing in a location that evaded the safety circuit leak check that is performed prior to surgery. This compromised ventilation and oxygenation in the middle of a surgery in which the patient is positioned prone and hence with a minimally accessible airway; it could have resulted in anoxic brain injury or death. The incident led us to reflect on the degree of thinness of the circuit's plastic.

机械呼吸器通常使用塑料电路装置将气体从呼吸机传递给患者。这些电路的结构完整性对于维持氧合至关重要。麻醉师,呼吸治疗师和其他重症监护专业人员依靠回路无缺陷。美国测试和材料协会维护医疗设备的标准,并有一个标准(题为麻醉呼吸管的标准规范),其中包括电路。该标准上次更新是在2008年,现已被撤销。缺乏明确的标准可能会导致质量下降——制造商故意但偷偷地降低材料质量以扩大利润空间的现象。对于塑料,这通常是以更薄的材料的形式出现的。在呼吸电路标准中描述的最小厚度将有助于确保产品质量,保持对机械损伤的容忍度,并避免泄漏。我们的印象是,近年来,许多商用呼吸回路中的塑料变得越来越薄。我们在椎板切除术中经历了一次回路泄漏,原因是手术前在一个位置的塑料管受损,逃避了安全回路泄漏检查。在手术中,患者俯卧,气道可达性最低,通气和氧合受损;这可能会导致缺氧脑损伤甚至死亡。这一事件引发了我们对电路塑料厚度的思考。
{"title":"Quality Fade in Medical Device Manufacturing: Thinness of Airway Breathing Circuit Plastic.","authors":"Rotem Naftalovich,&nbsp;Marko Oydanich,&nbsp;Tolga Berkman,&nbsp;Andrew John Iskander","doi":"10.2345/0899-8205-55.4.118","DOIUrl":"https://doi.org/10.2345/0899-8205-55.4.118","url":null,"abstract":"<p><p>Mechanical respirators typically use a plastic circuit apparatus to pass gases from the ventilator to the patient. Structural integrity of these circuits is crucial for maintaining oxygenation. Anesthesiologists, respiratory therapists, and other critical care professionals rely on the circuit to be free of defects. The American Society for Testing and Materials maintains standards of medical devices and had a standard (titled Standard Specification for Anesthesia Breathing Tubes) that included circuits. This standard, which was last updated in 2008, has since been withdrawn. Lack of a defined standard can invite quality fade-the phenomenon whereby manufacturers deliberately but surreptitiously reduce material quality to widen profit margins. With plastics, this is often in the form of thinner material. A minimum thickness delineated in the breathing circuit standard would help ensure product quality, maintain tolerance to mechanical insults, and avert leaks. Our impression is that over the recent years, the plastic in many of the commercially available breathing circuits has gotten thinner. We experienced a circuit leak in the middle of a laminectomy due to compromised plastic tubing in a location that evaded the safety circuit leak check that is performed prior to surgery. This compromised ventilation and oxygenation in the middle of a surgery in which the patient is positioned prone and hence with a minimally accessible airway; it could have resulted in anoxic brain injury or death. The incident led us to reflect on the degree of thinness of the circuit's plastic.</p>","PeriodicalId":35656,"journal":{"name":"Biomedical Instrumentation and Technology","volume":"55 4","pages":"118-120"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641416/pdf/i0899-8205-55-4-118.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39851014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biomedical Instrumentation and Technology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1